The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...
Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback